Letavis

📍 Stockholm, Sweden🗓 Founded 2015👥 6 employees💰 Last funded Mar 2025
Biotechnology Research🌐 letavis.com
Website LinkedIn
Letavis develops patented biotechnological solutions based on over 25 years of research. Our products, Amoravis™ and Scirona, are built on natural substances and have demonstrated effects in laboratory settings, practical field trials, and commercial applications. Our mission is to strengthen productivity, profitability, and resilience in agriculture through science-based biotechnological solutions. By enabling farmers to get more out of their existing resources, we contribute to a more sustainable and resilient global food system. In a time of rising input costs, market volatility, and an increasingly unpredictable climate, this becomes critical. Increased yields create better conditions for investment in modern technology and more sustainable production methods. Letavis was founded by Gustav Nadal and Ingemar Pongratz, combining extensive experience in entrepreneurship and molecular biology.
2
Total investors
0
Early stage
1
Mid stage
1
Late stage
2015
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
2
Frequently asked questions
Who invested in Letavis?
Letavis has 2 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did Letavis last raise funding?
The most recent investment in Letavis recorded on gritt.io was in March 2025.
When was Letavis founded?
Letavis was founded in 2015.
What industry is Letavis in?
Letavis operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Letavis based?
Letavis is headquartered in Stockholm, Sweden.